Global Poliovirus Vaccine Inactivated Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Poliovirus Vaccine Inactivated market size was valued at USD 708.4 million in 2023 and is forecast to a readjusted size of USD 945.6 million by 2030 with a CAGR of 4.2% during review period.
Inactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Poliovirus Vaccine Inactivated industry chain, the market status of Public (Human Diploid Cell, Monkey Kidney Cell), Private (Human Diploid Cell, Monkey Kidney Cell), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Poliovirus Vaccine Inactivated.
Regionally, the report analyzes the Poliovirus Vaccine Inactivated markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Poliovirus Vaccine Inactivated market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Poliovirus Vaccine Inactivated market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Poliovirus Vaccine Inactivated industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Human Diploid Cell, Monkey Kidney Cell).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Poliovirus Vaccine Inactivated market.
Regional Analysis: The report involves examining the Poliovirus Vaccine Inactivated market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Poliovirus Vaccine Inactivated market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Poliovirus Vaccine Inactivated:
Company Analysis: Report covers individual Poliovirus Vaccine Inactivated manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Poliovirus Vaccine Inactivated This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Public, Private).
Technology Analysis: Report covers specific technologies relevant to Poliovirus Vaccine Inactivated. It assesses the current state, advancements, and potential future developments in Poliovirus Vaccine Inactivated areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Poliovirus Vaccine Inactivated market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Poliovirus Vaccine Inactivated market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Poliovirus Vaccine Inactivated product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Poliovirus Vaccine Inactivated, with price, sales, revenue and global market share of Poliovirus Vaccine Inactivated from 2019 to 2024.
Chapter 3, the Poliovirus Vaccine Inactivated competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Poliovirus Vaccine Inactivated breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Poliovirus Vaccine Inactivated market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Poliovirus Vaccine Inactivated.
Chapter 14 and 15, to describe Poliovirus Vaccine Inactivated sales channel, distributors, customers, research findings and conclusion.
Inactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Poliovirus Vaccine Inactivated industry chain, the market status of Public (Human Diploid Cell, Monkey Kidney Cell), Private (Human Diploid Cell, Monkey Kidney Cell), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Poliovirus Vaccine Inactivated.
Regionally, the report analyzes the Poliovirus Vaccine Inactivated markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Poliovirus Vaccine Inactivated market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Poliovirus Vaccine Inactivated market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Poliovirus Vaccine Inactivated industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Human Diploid Cell, Monkey Kidney Cell).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Poliovirus Vaccine Inactivated market.
Regional Analysis: The report involves examining the Poliovirus Vaccine Inactivated market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Poliovirus Vaccine Inactivated market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Poliovirus Vaccine Inactivated:
Company Analysis: Report covers individual Poliovirus Vaccine Inactivated manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Poliovirus Vaccine Inactivated This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Public, Private).
Technology Analysis: Report covers specific technologies relevant to Poliovirus Vaccine Inactivated. It assesses the current state, advancements, and potential future developments in Poliovirus Vaccine Inactivated areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Poliovirus Vaccine Inactivated market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Poliovirus Vaccine Inactivated market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Human Diploid Cell
- Monkey Kidney Cell
- Public
- Private
- Sanofi
- GSK
- Serum Institute (Bilthoven Biologicals)
- IMBCA
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Poliovirus Vaccine Inactivated product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Poliovirus Vaccine Inactivated, with price, sales, revenue and global market share of Poliovirus Vaccine Inactivated from 2019 to 2024.
Chapter 3, the Poliovirus Vaccine Inactivated competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Poliovirus Vaccine Inactivated breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Poliovirus Vaccine Inactivated market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Poliovirus Vaccine Inactivated.
Chapter 14 and 15, to describe Poliovirus Vaccine Inactivated sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Poliovirus Vaccine Inactivated
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Poliovirus Vaccine Inactivated Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Human Diploid Cell
1.3.3 Monkey Kidney Cell
1.4 Market Analysis by Application
1.4.1 Overview: Global Poliovirus Vaccine Inactivated Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Public
1.4.3 Private
1.5 Global Poliovirus Vaccine Inactivated Market Size & Forecast
1.5.1 Global Poliovirus Vaccine Inactivated Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Poliovirus Vaccine Inactivated Sales Quantity (2019-2030)
1.5.3 Global Poliovirus Vaccine Inactivated Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Poliovirus Vaccine Inactivated Product and Services
2.1.4 Sanofi Poliovirus Vaccine Inactivated Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Poliovirus Vaccine Inactivated Product and Services
2.2.4 GSK Poliovirus Vaccine Inactivated Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GSK Recent Developments/Updates
2.3 Serum Institute (Bilthoven Biologicals)
2.3.1 Serum Institute (Bilthoven Biologicals) Details
2.3.2 Serum Institute (Bilthoven Biologicals) Major Business
2.3.3 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product and Services
2.3.4 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
2.4 IMBCA
2.4.1 IMBCA Details
2.4.2 IMBCA Major Business
2.4.3 IMBCA Poliovirus Vaccine Inactivated Product and Services
2.4.4 IMBCA Poliovirus Vaccine Inactivated Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 IMBCA Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POLIOVIRUS VACCINE INACTIVATED BY MANUFACTURER
3.1 Global Poliovirus Vaccine Inactivated Sales Quantity by Manufacturer (2019-2024)
3.2 Global Poliovirus Vaccine Inactivated Revenue by Manufacturer (2019-2024)
3.3 Global Poliovirus Vaccine Inactivated Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Poliovirus Vaccine Inactivated by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Poliovirus Vaccine Inactivated Manufacturer Market Share in 2023
3.4.2 Top 6 Poliovirus Vaccine Inactivated Manufacturer Market Share in 2023
3.5 Poliovirus Vaccine Inactivated Market: Overall Company Footprint Analysis
3.5.1 Poliovirus Vaccine Inactivated Market: Region Footprint
3.5.2 Poliovirus Vaccine Inactivated Market: Company Product Type Footprint
3.5.3 Poliovirus Vaccine Inactivated Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Poliovirus Vaccine Inactivated Market Size by Region
4.1.1 Global Poliovirus Vaccine Inactivated Sales Quantity by Region (2019-2030)
4.1.2 Global Poliovirus Vaccine Inactivated Consumption Value by Region (2019-2030)
4.1.3 Global Poliovirus Vaccine Inactivated Average Price by Region (2019-2030)
4.2 North America Poliovirus Vaccine Inactivated Consumption Value (2019-2030)
4.3 Europe Poliovirus Vaccine Inactivated Consumption Value (2019-2030)
4.4 Asia-Pacific Poliovirus Vaccine Inactivated Consumption Value (2019-2030)
4.5 South America Poliovirus Vaccine Inactivated Consumption Value (2019-2030)
4.6 Middle East and Africa Poliovirus Vaccine Inactivated Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2030)
5.2 Global Poliovirus Vaccine Inactivated Consumption Value by Type (2019-2030)
5.3 Global Poliovirus Vaccine Inactivated Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2030)
6.2 Global Poliovirus Vaccine Inactivated Consumption Value by Application (2019-2030)
6.3 Global Poliovirus Vaccine Inactivated Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2030)
7.2 North America Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2030)
7.3 North America Poliovirus Vaccine Inactivated Market Size by Country
7.3.1 North America Poliovirus Vaccine Inactivated Sales Quantity by Country (2019-2030)
7.3.2 North America Poliovirus Vaccine Inactivated Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2030)
8.2 Europe Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2030)
8.3 Europe Poliovirus Vaccine Inactivated Market Size by Country
8.3.1 Europe Poliovirus Vaccine Inactivated Sales Quantity by Country (2019-2030)
8.3.2 Europe Poliovirus Vaccine Inactivated Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Poliovirus Vaccine Inactivated Market Size by Region
9.3.1 Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Poliovirus Vaccine Inactivated Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2030)
10.2 South America Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2030)
10.3 South America Poliovirus Vaccine Inactivated Market Size by Country
10.3.1 South America Poliovirus Vaccine Inactivated Sales Quantity by Country (2019-2030)
10.3.2 South America Poliovirus Vaccine Inactivated Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Poliovirus Vaccine Inactivated Market Size by Country
11.3.1 Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Poliovirus Vaccine Inactivated Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Poliovirus Vaccine Inactivated Market Drivers
12.2 Poliovirus Vaccine Inactivated Market Restraints
12.3 Poliovirus Vaccine Inactivated Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Poliovirus Vaccine Inactivated and Key Manufacturers
13.2 Manufacturing Costs Percentage of Poliovirus Vaccine Inactivated
13.3 Poliovirus Vaccine Inactivated Production Process
13.4 Poliovirus Vaccine Inactivated Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Poliovirus Vaccine Inactivated Typical Distributors
14.3 Poliovirus Vaccine Inactivated Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Poliovirus Vaccine Inactivated
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Poliovirus Vaccine Inactivated Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Human Diploid Cell
1.3.3 Monkey Kidney Cell
1.4 Market Analysis by Application
1.4.1 Overview: Global Poliovirus Vaccine Inactivated Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Public
1.4.3 Private
1.5 Global Poliovirus Vaccine Inactivated Market Size & Forecast
1.5.1 Global Poliovirus Vaccine Inactivated Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Poliovirus Vaccine Inactivated Sales Quantity (2019-2030)
1.5.3 Global Poliovirus Vaccine Inactivated Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Poliovirus Vaccine Inactivated Product and Services
2.1.4 Sanofi Poliovirus Vaccine Inactivated Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Poliovirus Vaccine Inactivated Product and Services
2.2.4 GSK Poliovirus Vaccine Inactivated Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GSK Recent Developments/Updates
2.3 Serum Institute (Bilthoven Biologicals)
2.3.1 Serum Institute (Bilthoven Biologicals) Details
2.3.2 Serum Institute (Bilthoven Biologicals) Major Business
2.3.3 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product and Services
2.3.4 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
2.4 IMBCA
2.4.1 IMBCA Details
2.4.2 IMBCA Major Business
2.4.3 IMBCA Poliovirus Vaccine Inactivated Product and Services
2.4.4 IMBCA Poliovirus Vaccine Inactivated Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 IMBCA Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POLIOVIRUS VACCINE INACTIVATED BY MANUFACTURER
3.1 Global Poliovirus Vaccine Inactivated Sales Quantity by Manufacturer (2019-2024)
3.2 Global Poliovirus Vaccine Inactivated Revenue by Manufacturer (2019-2024)
3.3 Global Poliovirus Vaccine Inactivated Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Poliovirus Vaccine Inactivated by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Poliovirus Vaccine Inactivated Manufacturer Market Share in 2023
3.4.2 Top 6 Poliovirus Vaccine Inactivated Manufacturer Market Share in 2023
3.5 Poliovirus Vaccine Inactivated Market: Overall Company Footprint Analysis
3.5.1 Poliovirus Vaccine Inactivated Market: Region Footprint
3.5.2 Poliovirus Vaccine Inactivated Market: Company Product Type Footprint
3.5.3 Poliovirus Vaccine Inactivated Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Poliovirus Vaccine Inactivated Market Size by Region
4.1.1 Global Poliovirus Vaccine Inactivated Sales Quantity by Region (2019-2030)
4.1.2 Global Poliovirus Vaccine Inactivated Consumption Value by Region (2019-2030)
4.1.3 Global Poliovirus Vaccine Inactivated Average Price by Region (2019-2030)
4.2 North America Poliovirus Vaccine Inactivated Consumption Value (2019-2030)
4.3 Europe Poliovirus Vaccine Inactivated Consumption Value (2019-2030)
4.4 Asia-Pacific Poliovirus Vaccine Inactivated Consumption Value (2019-2030)
4.5 South America Poliovirus Vaccine Inactivated Consumption Value (2019-2030)
4.6 Middle East and Africa Poliovirus Vaccine Inactivated Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2030)
5.2 Global Poliovirus Vaccine Inactivated Consumption Value by Type (2019-2030)
5.3 Global Poliovirus Vaccine Inactivated Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2030)
6.2 Global Poliovirus Vaccine Inactivated Consumption Value by Application (2019-2030)
6.3 Global Poliovirus Vaccine Inactivated Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2030)
7.2 North America Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2030)
7.3 North America Poliovirus Vaccine Inactivated Market Size by Country
7.3.1 North America Poliovirus Vaccine Inactivated Sales Quantity by Country (2019-2030)
7.3.2 North America Poliovirus Vaccine Inactivated Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2030)
8.2 Europe Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2030)
8.3 Europe Poliovirus Vaccine Inactivated Market Size by Country
8.3.1 Europe Poliovirus Vaccine Inactivated Sales Quantity by Country (2019-2030)
8.3.2 Europe Poliovirus Vaccine Inactivated Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Poliovirus Vaccine Inactivated Market Size by Region
9.3.1 Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Poliovirus Vaccine Inactivated Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2030)
10.2 South America Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2030)
10.3 South America Poliovirus Vaccine Inactivated Market Size by Country
10.3.1 South America Poliovirus Vaccine Inactivated Sales Quantity by Country (2019-2030)
10.3.2 South America Poliovirus Vaccine Inactivated Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Poliovirus Vaccine Inactivated Market Size by Country
11.3.1 Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Poliovirus Vaccine Inactivated Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Poliovirus Vaccine Inactivated Market Drivers
12.2 Poliovirus Vaccine Inactivated Market Restraints
12.3 Poliovirus Vaccine Inactivated Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Poliovirus Vaccine Inactivated and Key Manufacturers
13.2 Manufacturing Costs Percentage of Poliovirus Vaccine Inactivated
13.3 Poliovirus Vaccine Inactivated Production Process
13.4 Poliovirus Vaccine Inactivated Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Poliovirus Vaccine Inactivated Typical Distributors
14.3 Poliovirus Vaccine Inactivated Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Poliovirus Vaccine Inactivated Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Poliovirus Vaccine Inactivated Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Poliovirus Vaccine Inactivated Product and Services
Table 6. Sanofi Poliovirus Vaccine Inactivated Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Poliovirus Vaccine Inactivated Product and Services
Table 11. GSK Poliovirus Vaccine Inactivated Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GSK Recent Developments/Updates
Table 13. Serum Institute (Bilthoven Biologicals) Basic Information, Manufacturing Base and Competitors
Table 14. Serum Institute (Bilthoven Biologicals) Major Business
Table 15. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product and Services
Table 16. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
Table 18. IMBCA Basic Information, Manufacturing Base and Competitors
Table 19. IMBCA Major Business
Table 20. IMBCA Poliovirus Vaccine Inactivated Product and Services
Table 21. IMBCA Poliovirus Vaccine Inactivated Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. IMBCA Recent Developments/Updates
Table 23. Global Poliovirus Vaccine Inactivated Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 24. Global Poliovirus Vaccine Inactivated Revenue by Manufacturer (2019-2024) & (USD Million)
Table 25. Global Poliovirus Vaccine Inactivated Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 26. Market Position of Manufacturers in Poliovirus Vaccine Inactivated, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 27. Head Office and Poliovirus Vaccine Inactivated Production Site of Key Manufacturer
Table 28. Poliovirus Vaccine Inactivated Market: Company Product Type Footprint
Table 29. Poliovirus Vaccine Inactivated Market: Company Product Application Footprint
Table 30. Poliovirus Vaccine Inactivated New Market Entrants and Barriers to Market Entry
Table 31. Poliovirus Vaccine Inactivated Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Poliovirus Vaccine Inactivated Sales Quantity by Region (2019-2024) & (K Units)
Table 33. Global Poliovirus Vaccine Inactivated Sales Quantity by Region (2025-2030) & (K Units)
Table 34. Global Poliovirus Vaccine Inactivated Consumption Value by Region (2019-2024) & (USD Million)
Table 35. Global Poliovirus Vaccine Inactivated Consumption Value by Region (2025-2030) & (USD Million)
Table 36. Global Poliovirus Vaccine Inactivated Average Price by Region (2019-2024) & (USD/Unit)
Table 37. Global Poliovirus Vaccine Inactivated Average Price by Region (2025-2030) & (USD/Unit)
Table 38. Global Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2024) & (K Units)
Table 39. Global Poliovirus Vaccine Inactivated Sales Quantity by Type (2025-2030) & (K Units)
Table 40. Global Poliovirus Vaccine Inactivated Consumption Value by Type (2019-2024) & (USD Million)
Table 41. Global Poliovirus Vaccine Inactivated Consumption Value by Type (2025-2030) & (USD Million)
Table 42. Global Poliovirus Vaccine Inactivated Average Price by Type (2019-2024) & (USD/Unit)
Table 43. Global Poliovirus Vaccine Inactivated Average Price by Type (2025-2030) & (USD/Unit)
Table 44. Global Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2024) & (K Units)
Table 45. Global Poliovirus Vaccine Inactivated Sales Quantity by Application (2025-2030) & (K Units)
Table 46. Global Poliovirus Vaccine Inactivated Consumption Value by Application (2019-2024) & (USD Million)
Table 47. Global Poliovirus Vaccine Inactivated Consumption Value by Application (2025-2030) & (USD Million)
Table 48. Global Poliovirus Vaccine Inactivated Average Price by Application (2019-2024) & (USD/Unit)
Table 49. Global Poliovirus Vaccine Inactivated Average Price by Application (2025-2030) & (USD/Unit)
Table 50. North America Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2024) & (K Units)
Table 51. North America Poliovirus Vaccine Inactivated Sales Quantity by Type (2025-2030) & (K Units)
Table 52. North America Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2024) & (K Units)
Table 53. North America Poliovirus Vaccine Inactivated Sales Quantity by Application (2025-2030) & (K Units)
Table 54. North America Poliovirus Vaccine Inactivated Sales Quantity by Country (2019-2024) & (K Units)
Table 55. North America Poliovirus Vaccine Inactivated Sales Quantity by Country (2025-2030) & (K Units)
Table 56. North America Poliovirus Vaccine Inactivated Consumption Value by Country (2019-2024) & (USD Million)
Table 57. North America Poliovirus Vaccine Inactivated Consumption Value by Country (2025-2030) & (USD Million)
Table 58. Europe Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2024) & (K Units)
Table 59. Europe Poliovirus Vaccine Inactivated Sales Quantity by Type (2025-2030) & (K Units)
Table 60. Europe Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2024) & (K Units)
Table 61. Europe Poliovirus Vaccine Inactivated Sales Quantity by Application (2025-2030) & (K Units)
Table 62. Europe Poliovirus Vaccine Inactivated Sales Quantity by Country (2019-2024) & (K Units)
Table 63. Europe Poliovirus Vaccine Inactivated Sales Quantity by Country (2025-2030) & (K Units)
Table 64. Europe Poliovirus Vaccine Inactivated Consumption Value by Country (2019-2024) & (USD Million)
Table 65. Europe Poliovirus Vaccine Inactivated Consumption Value by Country (2025-2030) & (USD Million)
Table 66. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2024) & (K Units)
Table 67. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Type (2025-2030) & (K Units)
Table 68. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2024) & (K Units)
Table 69. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Application (2025-2030) & (K Units)
Table 70. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Region (2019-2024) & (K Units)
Table 71. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Region (2025-2030) & (K Units)
Table 72. Asia-Pacific Poliovirus Vaccine Inactivated Consumption Value by Region (2019-2024) & (USD Million)
Table 73. Asia-Pacific Poliovirus Vaccine Inactivated Consumption Value by Region (2025-2030) & (USD Million)
Table 74. South America Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2024) & (K Units)
Table 75. South America Poliovirus Vaccine Inactivated Sales Quantity by Type (2025-2030) & (K Units)
Table 76. South America Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2024) & (K Units)
Table 77. South America Poliovirus Vaccine Inactivated Sales Quantity by Application (2025-2030) & (K Units)
Table 78. South America Poliovirus Vaccine Inactivated Sales Quantity by Country (2019-2024) & (K Units)
Table 79. South America Poliovirus Vaccine Inactivated Sales Quantity by Country (2025-2030) & (K Units)
Table 80. South America Poliovirus Vaccine Inactivated Consumption Value by Country (2019-2024) & (USD Million)
Table 81. South America Poliovirus Vaccine Inactivated Consumption Value by Country (2025-2030) & (USD Million)
Table 82. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2024) & (K Units)
Table 83. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Type (2025-2030) & (K Units)
Table 84. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2024) & (K Units)
Table 85. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Application (2025-2030) & (K Units)
Table 86. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Region (2019-2024) & (K Units)
Table 87. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Region (2025-2030) & (K Units)
Table 88. Middle East & Africa Poliovirus Vaccine Inactivated Consumption Value by Region (2019-2024) & (USD Million)
Table 89. Middle East & Africa Poliovirus Vaccine Inactivated Consumption Value by Region (2025-2030) & (USD Million)
Table 90. Poliovirus Vaccine Inactivated Raw Material
Table 91. Key Manufacturers of Poliovirus Vaccine Inactivated Raw Materials
Table 92. Poliovirus Vaccine Inactivated Typical Distributors
Table 93. Poliovirus Vaccine Inactivated Typical Customers
Table 1. Global Poliovirus Vaccine Inactivated Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Poliovirus Vaccine Inactivated Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Poliovirus Vaccine Inactivated Product and Services
Table 6. Sanofi Poliovirus Vaccine Inactivated Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Poliovirus Vaccine Inactivated Product and Services
Table 11. GSK Poliovirus Vaccine Inactivated Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GSK Recent Developments/Updates
Table 13. Serum Institute (Bilthoven Biologicals) Basic Information, Manufacturing Base and Competitors
Table 14. Serum Institute (Bilthoven Biologicals) Major Business
Table 15. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product and Services
Table 16. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
Table 18. IMBCA Basic Information, Manufacturing Base and Competitors
Table 19. IMBCA Major Business
Table 20. IMBCA Poliovirus Vaccine Inactivated Product and Services
Table 21. IMBCA Poliovirus Vaccine Inactivated Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. IMBCA Recent Developments/Updates
Table 23. Global Poliovirus Vaccine Inactivated Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 24. Global Poliovirus Vaccine Inactivated Revenue by Manufacturer (2019-2024) & (USD Million)
Table 25. Global Poliovirus Vaccine Inactivated Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 26. Market Position of Manufacturers in Poliovirus Vaccine Inactivated, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 27. Head Office and Poliovirus Vaccine Inactivated Production Site of Key Manufacturer
Table 28. Poliovirus Vaccine Inactivated Market: Company Product Type Footprint
Table 29. Poliovirus Vaccine Inactivated Market: Company Product Application Footprint
Table 30. Poliovirus Vaccine Inactivated New Market Entrants and Barriers to Market Entry
Table 31. Poliovirus Vaccine Inactivated Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Poliovirus Vaccine Inactivated Sales Quantity by Region (2019-2024) & (K Units)
Table 33. Global Poliovirus Vaccine Inactivated Sales Quantity by Region (2025-2030) & (K Units)
Table 34. Global Poliovirus Vaccine Inactivated Consumption Value by Region (2019-2024) & (USD Million)
Table 35. Global Poliovirus Vaccine Inactivated Consumption Value by Region (2025-2030) & (USD Million)
Table 36. Global Poliovirus Vaccine Inactivated Average Price by Region (2019-2024) & (USD/Unit)
Table 37. Global Poliovirus Vaccine Inactivated Average Price by Region (2025-2030) & (USD/Unit)
Table 38. Global Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2024) & (K Units)
Table 39. Global Poliovirus Vaccine Inactivated Sales Quantity by Type (2025-2030) & (K Units)
Table 40. Global Poliovirus Vaccine Inactivated Consumption Value by Type (2019-2024) & (USD Million)
Table 41. Global Poliovirus Vaccine Inactivated Consumption Value by Type (2025-2030) & (USD Million)
Table 42. Global Poliovirus Vaccine Inactivated Average Price by Type (2019-2024) & (USD/Unit)
Table 43. Global Poliovirus Vaccine Inactivated Average Price by Type (2025-2030) & (USD/Unit)
Table 44. Global Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2024) & (K Units)
Table 45. Global Poliovirus Vaccine Inactivated Sales Quantity by Application (2025-2030) & (K Units)
Table 46. Global Poliovirus Vaccine Inactivated Consumption Value by Application (2019-2024) & (USD Million)
Table 47. Global Poliovirus Vaccine Inactivated Consumption Value by Application (2025-2030) & (USD Million)
Table 48. Global Poliovirus Vaccine Inactivated Average Price by Application (2019-2024) & (USD/Unit)
Table 49. Global Poliovirus Vaccine Inactivated Average Price by Application (2025-2030) & (USD/Unit)
Table 50. North America Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2024) & (K Units)
Table 51. North America Poliovirus Vaccine Inactivated Sales Quantity by Type (2025-2030) & (K Units)
Table 52. North America Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2024) & (K Units)
Table 53. North America Poliovirus Vaccine Inactivated Sales Quantity by Application (2025-2030) & (K Units)
Table 54. North America Poliovirus Vaccine Inactivated Sales Quantity by Country (2019-2024) & (K Units)
Table 55. North America Poliovirus Vaccine Inactivated Sales Quantity by Country (2025-2030) & (K Units)
Table 56. North America Poliovirus Vaccine Inactivated Consumption Value by Country (2019-2024) & (USD Million)
Table 57. North America Poliovirus Vaccine Inactivated Consumption Value by Country (2025-2030) & (USD Million)
Table 58. Europe Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2024) & (K Units)
Table 59. Europe Poliovirus Vaccine Inactivated Sales Quantity by Type (2025-2030) & (K Units)
Table 60. Europe Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2024) & (K Units)
Table 61. Europe Poliovirus Vaccine Inactivated Sales Quantity by Application (2025-2030) & (K Units)
Table 62. Europe Poliovirus Vaccine Inactivated Sales Quantity by Country (2019-2024) & (K Units)
Table 63. Europe Poliovirus Vaccine Inactivated Sales Quantity by Country (2025-2030) & (K Units)
Table 64. Europe Poliovirus Vaccine Inactivated Consumption Value by Country (2019-2024) & (USD Million)
Table 65. Europe Poliovirus Vaccine Inactivated Consumption Value by Country (2025-2030) & (USD Million)
Table 66. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2024) & (K Units)
Table 67. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Type (2025-2030) & (K Units)
Table 68. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2024) & (K Units)
Table 69. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Application (2025-2030) & (K Units)
Table 70. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Region (2019-2024) & (K Units)
Table 71. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity by Region (2025-2030) & (K Units)
Table 72. Asia-Pacific Poliovirus Vaccine Inactivated Consumption Value by Region (2019-2024) & (USD Million)
Table 73. Asia-Pacific Poliovirus Vaccine Inactivated Consumption Value by Region (2025-2030) & (USD Million)
Table 74. South America Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2024) & (K Units)
Table 75. South America Poliovirus Vaccine Inactivated Sales Quantity by Type (2025-2030) & (K Units)
Table 76. South America Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2024) & (K Units)
Table 77. South America Poliovirus Vaccine Inactivated Sales Quantity by Application (2025-2030) & (K Units)
Table 78. South America Poliovirus Vaccine Inactivated Sales Quantity by Country (2019-2024) & (K Units)
Table 79. South America Poliovirus Vaccine Inactivated Sales Quantity by Country (2025-2030) & (K Units)
Table 80. South America Poliovirus Vaccine Inactivated Consumption Value by Country (2019-2024) & (USD Million)
Table 81. South America Poliovirus Vaccine Inactivated Consumption Value by Country (2025-2030) & (USD Million)
Table 82. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Type (2019-2024) & (K Units)
Table 83. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Type (2025-2030) & (K Units)
Table 84. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Application (2019-2024) & (K Units)
Table 85. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Application (2025-2030) & (K Units)
Table 86. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Region (2019-2024) & (K Units)
Table 87. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity by Region (2025-2030) & (K Units)
Table 88. Middle East & Africa Poliovirus Vaccine Inactivated Consumption Value by Region (2019-2024) & (USD Million)
Table 89. Middle East & Africa Poliovirus Vaccine Inactivated Consumption Value by Region (2025-2030) & (USD Million)
Table 90. Poliovirus Vaccine Inactivated Raw Material
Table 91. Key Manufacturers of Poliovirus Vaccine Inactivated Raw Materials
Table 92. Poliovirus Vaccine Inactivated Typical Distributors
Table 93. Poliovirus Vaccine Inactivated Typical Customers
LIST OF FIGURES
Figure 1. Poliovirus Vaccine Inactivated Picture
Figure 2. Global Poliovirus Vaccine Inactivated Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Poliovirus Vaccine Inactivated Consumption Value Market Share by Type in 2023
Figure 4. Human Diploid Cell Examples
Figure 5. Monkey Kidney Cell Examples
Figure 6. Global Poliovirus Vaccine Inactivated Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Poliovirus Vaccine Inactivated Consumption Value Market Share by Application in 2023
Figure 8. Public Examples
Figure 9. Private Examples
Figure 10. Global Poliovirus Vaccine Inactivated Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Poliovirus Vaccine Inactivated Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Poliovirus Vaccine Inactivated Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Poliovirus Vaccine Inactivated Average Price (2019-2030) & (USD/Unit)
Figure 14. Global Poliovirus Vaccine Inactivated Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Poliovirus Vaccine Inactivated Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Poliovirus Vaccine Inactivated by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Poliovirus Vaccine Inactivated Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Poliovirus Vaccine Inactivated Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Poliovirus Vaccine Inactivated Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Poliovirus Vaccine Inactivated Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Poliovirus Vaccine Inactivated Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Poliovirus Vaccine Inactivated Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Poliovirus Vaccine Inactivated Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Poliovirus Vaccine Inactivated Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Poliovirus Vaccine Inactivated Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Poliovirus Vaccine Inactivated Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Poliovirus Vaccine Inactivated Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Poliovirus Vaccine Inactivated Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global Poliovirus Vaccine Inactivated Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Poliovirus Vaccine Inactivated Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Poliovirus Vaccine Inactivated Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Poliovirus Vaccine Inactivated Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Poliovirus Vaccine Inactivated Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Poliovirus Vaccine Inactivated Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Poliovirus Vaccine Inactivated Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Poliovirus Vaccine Inactivated Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Poliovirus Vaccine Inactivated Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Poliovirus Vaccine Inactivated Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Poliovirus Vaccine Inactivated Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Poliovirus Vaccine Inactivated Consumption Value Market Share by Region (2019-2030)
Figure 52. China Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Poliovirus Vaccine Inactivated Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Poliovirus Vaccine Inactivated Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Poliovirus Vaccine Inactivated Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Poliovirus Vaccine Inactivated Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Poliovirus Vaccine Inactivated Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Poliovirus Vaccine Inactivated Market Drivers
Figure 73. Poliovirus Vaccine Inactivated Market Restraints
Figure 74. Poliovirus Vaccine Inactivated Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Poliovirus Vaccine Inactivated in 2023
Figure 77. Manufacturing Process Analysis of Poliovirus Vaccine Inactivated
Figure 78. Poliovirus Vaccine Inactivated Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Poliovirus Vaccine Inactivated Picture
Figure 2. Global Poliovirus Vaccine Inactivated Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Poliovirus Vaccine Inactivated Consumption Value Market Share by Type in 2023
Figure 4. Human Diploid Cell Examples
Figure 5. Monkey Kidney Cell Examples
Figure 6. Global Poliovirus Vaccine Inactivated Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Poliovirus Vaccine Inactivated Consumption Value Market Share by Application in 2023
Figure 8. Public Examples
Figure 9. Private Examples
Figure 10. Global Poliovirus Vaccine Inactivated Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Poliovirus Vaccine Inactivated Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Poliovirus Vaccine Inactivated Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Poliovirus Vaccine Inactivated Average Price (2019-2030) & (USD/Unit)
Figure 14. Global Poliovirus Vaccine Inactivated Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Poliovirus Vaccine Inactivated Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Poliovirus Vaccine Inactivated by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Poliovirus Vaccine Inactivated Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Poliovirus Vaccine Inactivated Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Poliovirus Vaccine Inactivated Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Poliovirus Vaccine Inactivated Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Poliovirus Vaccine Inactivated Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Poliovirus Vaccine Inactivated Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Poliovirus Vaccine Inactivated Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Poliovirus Vaccine Inactivated Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Poliovirus Vaccine Inactivated Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Poliovirus Vaccine Inactivated Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Poliovirus Vaccine Inactivated Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Poliovirus Vaccine Inactivated Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global Poliovirus Vaccine Inactivated Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Poliovirus Vaccine Inactivated Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Poliovirus Vaccine Inactivated Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Poliovirus Vaccine Inactivated Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Poliovirus Vaccine Inactivated Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Poliovirus Vaccine Inactivated Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Poliovirus Vaccine Inactivated Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Poliovirus Vaccine Inactivated Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Poliovirus Vaccine Inactivated Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Poliovirus Vaccine Inactivated Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Poliovirus Vaccine Inactivated Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Poliovirus Vaccine Inactivated Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Poliovirus Vaccine Inactivated Consumption Value Market Share by Region (2019-2030)
Figure 52. China Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Poliovirus Vaccine Inactivated Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Poliovirus Vaccine Inactivated Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Poliovirus Vaccine Inactivated Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Poliovirus Vaccine Inactivated Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Poliovirus Vaccine Inactivated Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Poliovirus Vaccine Inactivated Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Poliovirus Vaccine Inactivated Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Poliovirus Vaccine Inactivated Market Drivers
Figure 73. Poliovirus Vaccine Inactivated Market Restraints
Figure 74. Poliovirus Vaccine Inactivated Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Poliovirus Vaccine Inactivated in 2023
Figure 77. Manufacturing Process Analysis of Poliovirus Vaccine Inactivated
Figure 78. Poliovirus Vaccine Inactivated Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
